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Abstract
 .Cholecystokinin CCK and related peptides such as gastrin are important regulators of gastric smooth muscle
contraction. Several studies have shown that these effects of CCK and gastrin are mediated by CCK receptors. However,B
recent studies suggest the expression of an additional CCK receptor subtype distinct from CCK receptors in this tissue.B
This study was designed to distinguish between CCK and CCK receptors on guinea-pig stomach smooth muscle cellsA B
and to evaluate these cells for additional receptor subtypes. We cloned these receptors by hybridization screening of a
guinea-pig smooth muscle cDNA library using 32 P random primed labeled cDNA probes from the recently cloned rat
CCK and CCK receptor coding regions. In addition to clones representing the CCK subtype, clones of CCK receptorA B B A
subtype, but no additional CCK receptor subtypes, could be identified. All isolated clones displayed highly homologous
nucleotide sequences in comparison to previously characterized CCK and CCK receptors from different species. TheA B
results of cDNA hybridization at different levels of stringency and Southern blot analysis using guinea-pig genomic DNA
suggest that it is unlikely that additional CCK receptors despite CCK and CCK receptors exist in stomach smoothA B
muscle. q 1997 Elsevier Science B.V.
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1. Introduction
 .Cholecystokinin CCK and gastrin are naturally
occurring structurally related peptides displaying a
homology in the common COOH-terminal penta-
w xpeptide 1–3 . Receptors for these peptides can be
distinguished pharmacologically by their affinities for
gastrin, CCK, gastrin-4, and several receptor prefer-
w xring antagonists 1,2 . Although pancreas, gallblad-
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der, and parietal cells are the principal targets for
gastrin and CCK, these peptides play a major physio-
logical role in the regulation of gastrointestinal motil-
w xity 4–8 . Although this effect is largely mediated by
neural CCK receptors, it was shown that gallbladder
and stomach express CCK receptors on smooth mus-
w xcle cells 5,6,9–11 . However, the type of CCK re-
ceptor on gastric smooth muscle has not been identi-
fied with certainty.
In guinea-pig, CCK and gastrin can cause contrac-
tion in gastric smooth muscle cells, which were
w xseparated from neural structures 6,9,10,12,13 . Sev-
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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eral authors suggest that the contractile response of
gastric smooth muscle cells is only mediated by
CCK receptors, which display a nearly equal affin-B
ity for CCK-8 and gastrin and interact preferentially
w xwith L-365,260 12,13 . However, there is evidence
for expression of additional CCK receptor subtypes
in gastric smooth muscle, such as the CCK receptorA
which acts preferentially with CCK-8 and L-364,718
w x6,10 . In addition, studies on isolated tissue assays
describe the pharmacological properties of two dis-
tinct CCK receptors, which can be discriminated onB
w xthe basis of differences of antagonist binding 14 . It
is unclear, whether an additional CCK receptor sub-
type described in ileal muscle strips, which interacts
w xpreferentially with gastrin and L-365,260 5 , is also
expressed in gastric smooth muscle.
Recent receptor cloning studies could identify only
two types of CCK receptors in a variety of different
w xtissues, the CCK and CCK receptors 15–23 .A B
In spite of the controversies concerning the type of
CCK receptor in stomach smooth muscle, cells de-
rived from this tissue have not been evaluated for
additional cDNAs distinct from the already cloned
CCK receptor subtypes. We therefore screened a
cDNA library constructed from mRNA from dis-
persed smooth muscle cells which were prepared
according the techniques described by Grider and
w xMakhlouf 6 using the cDNAs of the previously
cloned two receptors, the CCK and CCK receptorsA B
w x21–23 , to identify the receptor types expressed in
this tissue.
2. Materials and methods
2.1. Tissue procurement, smooth muscle cell prepara-
tion and mRNA isolation
 .Male Pirbright-white guinea-pigs 150–175 g were
obtained from the animals section, University Hospi-
tal Eppendorf. Guinea-pigs were killed, several tis-
sues were removed and immediately snap frozen in
liquid nitrogen and stored at y708C until further
processing. The stomach was resected and the py-
lorus, corpus and antrum was chosen for the prepara-
tion of smooth muscle, which was done according
w xmethods described previously 5,6 . Briefly, the ep-
ithelial layer was removed by mechanical blunt dis-
section and strips 1–2 mm wide and 10–13 mm
.long from the muscle layer were incubated with
collagenase 0.1% collagenase type II and 0.1% soy-
.bean trypsin inhibitor, 2= 45 min . The medium was
prepared as follows: 120 nM NaCl, 4 nM KCl, 2.6
nM KH PO , 2 nM CaCl , 0.6 nM MgCl , 25 nM2 4 2 2
N-2-hydroxyethylpiperazine-NX-2-ethanesulfonic acid
 .Hepes , 14 nM glucose, and 2.1% Eagle’s essential
amino acid mixture. The partially digested muscle
strips were allowed to disperse for 15 min after the
second incubation period. This was performed in
enzyme-free medium. This step was followed by
harvesting the cells through 500-mm Nytrex mesh.
The purity of the smooth muscle preparation was
confirmed by microscopy and revealed the absence of
epithelial cells or cells from neural origin. The prepa-
ration resulted in isolated smooth muscle cells. These
cells and other tissues were mechanically degraded
and total RNA was extracted using established meth-
ods, the integrity and purity of the extracted RNA
was confirmed by electrophoretic evaluation and
spectrophotometrical analysis as described before
w x  .q24 . Polyadenylated poly A mRNA was isolated
 .  .using oligo dT -cellulose BRL, USA .
2.2. Construction of a guinea-pig stomach cDNA
library and isolation of guinea-pig smooth muscle
cDNA clones
 .Oligo dT primed cDNA)1.8 kB was size se-
lected by agarose gel electrophoresis, electroeluted,
 .ligated into the lambda Zap vector Stratagene, USA
w xaccording to standard protocols 24 . Approximately
7.5=105 plaques were screened with a 32P-labeled,
randomly primed probe specific activity, 3000
.Cirmmol, 1 Cis37 GBq; Amersham, USA gener-
ated from the rat pancreatic CCK receptor and ratA
w xbrain CCK receptor coding region 21,23 . PhageB
DNA was transferred to Nylon membranes
 .Amersham, USA . Duplicate filters were washed
once at room temperature for 5 min in 2= standard
saline citrate SSC; 2=SSCs300 mM NaClr3 mM
.sodium citrate and 0.1% SDS and three times at
558C for 20 min in 0.1=SSC and 0.1% SDS, dried
and examined by autoradiography after 2 days. Posi-
tive phages were plaque purified and the receptor
encoding plasmids cDNA inserts were excision-re-
scued from lambda Zap clones by superinfection with
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R-408 helper phages and subcloned into the vector
pcDNA-1 according to protocols supplied by the
 .manufacturer Invitrogen, USA .
2.3. E˝aluation of the cDNA library for cDNA frag-
ments encoding additional guinea-pig smooth muscle
CCK receptor subtype
In order to isolate additional clones with sequence
homology to the cDNAs of the guinea-pig smooth
muscle CCK and CCK receptors, all filters usedA B
for the first round of hybridization screening were
rescreened with the same probes under conditions of
low stringency. After stripping the filters of residual
radioactivity the filters were rehybridized and subse-
quently washed once at room temperature for 5 min
in 2=SSC and 0.1% SDS and three times at 408C
for 20 min in 2=SSC and 0.1% SDS, dried and
examined by autoradiography after 2 days. The auto-
radiography films were compared to the correspond-
ing films which were produced during the original
high-stringency hybridization and evaluated for addi-
tional positive hybridization signals.
2.4. DNA sequencing
At least two cDNA clones isolated from the
guinea-pig stomach smooth muscle cDNA library
were sequenced using the cycle sequencing technique
according to protocols supplied by the manufacturer
 .BRL, USA .
2.5. Northern blot analysis of mRNAs
 .qPoly A mRNA was isolated from guinea-pig
stomach smooth muscle, brain, liver and skeletal
w xmuscle as previously described 24 . Four micro-
 .qgrams of poly A mRNA per lane were elec-
trophoretically separated on a 1.4% agaroserformal-
dehyde gel followed by capillary transfer onto a
 .Nylon membrane Amersham . These membranes
were hybridized with the guinea-pig stomach CCKA
and subsequently with CCK receptor probeB
w x 3217,19,24 labeled with P by random priming,
washed under high-stringency conditions 3= 20
.min at 558C in 0.2=SSC and 0.1% SDS and exam-
ined by autoradiography after 6-day exposure.
2.6. Southern blot analysis
10 mg of genomic DNA were digested using a
c o m b in a t io n o f re s tr ic t io n e n z y m e s
 .BamH1rBsPMII, BamH1rXmaI according to the
protocols supplied by the manufacturer Boehringer,
.FRG . As a negative control a DNAse digestion of
the genomic DNA was performed, using the same
combination of restriction enzymes. The digested
DNA was electrophoretically separated on a 2%
agarose gel. This step was followed by capillary
 .transfer onto a Nylon membrane Amersham . This
membrane was hybridized with the guinea-pig stom-
ach CCK , and subsequently with CCK receptorA B
probe labeled with 32P by random priming, washed
under low-stringency conditions 3= 20 min at 408C
.in 2=SSC and 0.1% SDS and examined by auto-
radiography after 10-h exposure. The blots were
stripped from radioactivity and rehybridized under
high-stringency conditions 3= 20 min at 558C in
.0.2=SSC and 0.1% SDS and examined by auto-
radiography after 10-h exposure.
2.7. Expression of CCK and CCK receptor cDNAsA B
in mammalian cells
The CCK and CCK receptor cDNA codingA B
region NOT I fragment insert was subcloned into the
 .corresponding site of pcDNAI Invitrogen . This con-
struct was used to transfect a near-confluent 100-mm
tissue culture plate containing approximately 1=106
COS-7 cells using a DEAErdextran method previ-
w xously described 21,23,24 . Approximately 48 h post
transfection, the cells were washed twice with phos-
 .phate-buffered saline PBS , pH 7.4, 0.1% BSA, at
48C, scraped from the plate in Dulbecco’s Modified
 .Eagle Medium Gibco, USA with bovine serum
 .albumin Boehringer, FRG 1 mgrml, at 408C, cen-
 .trifuged 400=g and resuspended in the same
medium at 408C. 500 ml of resuspended cells were
incubated for 60 min at 378C with 50 pM of the
radiolabeled hormone, 125I-Bolton-Hunter labeled
 .CCK-8 2200 Cirmmol, NEN, USA , either with or
without varying concentrations of unlabeled agonist
or antagonist. Cells were subsequently washed three
times with 2 ml PBS, 0.1% BSA, at 48C by filtration
 .on glass fiber filters Whatman, UK using a suction
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 .manifold Millipore, USA . Filters were assayed for
bound radioactivity, which was determined by a
 .gamma scintillation counter Packard, USA .
3. Results
3.1. cDNA cloning and structure of the guinea-pig
stomach CCK receptorA
 .Screening of an oligo dT primed cDNA library
constructed in the lambda Zap vector with a 32P
random primed labeled probe corresponding to the
guinea-pig gallbladder CCK receptor cDNA underA
high-stringency conditions identified 13 strongly hy-
bridizing clones. All clones were isolated as single
clones after 3 rounds of plaque purification. Two
 .clones with the longest cDNA insert 2.9 kB were
selected for further structural and functional charac-
terization. Cycle sequencing of these products re-
vealed a single long open-reading frame specifying a
450 amino acid protein. There are three N-linked
glycosylation sites in the N-terminal extracellular
portion of the protein and nine conserved cysteine
residues. The deduced amino acid sequence displays
features typical of guanine nucleotide binding protein
 .G-protein coupled receptors, such as seven trans-
membrane segments of 20–27 amino acid residues.
Alignment of the amino acid sequence deduced from
the guinea-pig stomach CCK cDNA clone with theA
guinea-pig gallbladder, human gallbladder and rat
pancreas CCK receptor amino acid sequence showsA
a homology of 100%, 89% and 90%, respectively
w x17,18,23 .
3.2. cDNA cloning and structure of the guinea-pig
stomach CCK receptorB
 .Screening of an oligo dT primed cDNA library
constructed in lambda Zap vector with a 32P random
primed labeled probe corresponding to the guinea-pig
gallbladder CCK receptor cDNA under high-strin-B
gency conditions identified 52 strongly hybridizing
clones. All clones were isolated as single clones after
3 rounds of plaque purification. Two clones with the
 .longest cDNA insert 3.9 kB were selected for fur-
ther structural and functional characterization. Se-
quence analysis of these products revealed a single
long open-reading frame specifying 453 amino acids.
There are three N-linked glycosylation sites in the
N-terminal extracellular portion of the protein and
nine conserved cysteine residues. Like in the CCKA
receptor the analysis of the deduced amino acid
sequence reveals features of a receptor coupled to a
G-protein. Alignment of the amino acid sequence
deduced from the guinea-pig stomach CCK cDNAB
clone with the guinea-pig gallbladder, human gall-
bladder and rat pancreas CCK receptor amino acidB
sequence shows a homology of 100%, 90% and 91%,
w xrespectively 15,16,19,20,22 .
3.3. Hybridization screening of the libraries under
low-stringency conditions
All filters used in the first round of hybridization
screening were rehybridized under conditions of low
stringency. Both the CCK and the CCK receptorA B
probe were evaluated. The results were compared
with the findings of high-stringency hybridization.
All plaques representing the CCK receptor cDNAA
could be identified by low-stringency hybridization
using the CCK receptor and visa-versa under theB
same conditions. No additional positive plaques sug-
gesting homologous cDNA fragments after examina-
tion by autoradiography after 2, 4 or 6 days were
seen.
Fig. 1. High-stringency Northern Blot analysis of organ and
 .qtissue specific poly A mRNA using the CCK receptor cDNAA
 .  .probe left and the CCK receptor cDNA probe right underB
high-stringency conditions. The transcript size is indicated at the
right-hand side of the figure.
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3.4. Northern blot hybridization
High-stringency Northern blot analysis of organ
 .qand tissue specific poly A mRNA from guinea-pig
stomach smooth muscle, brain, liver and skeletal
muscle using the CCK receptor cDNA probe re-B
vealed a 2.4-kB hybridizing transcript in guinea-pig
stomach smooth muscle and brain. No hybridization
was detected in tissues like liver and skeletal muscle
which are known not to express the receptor. Screen-
ing the same blot under identical conditions using the
CCK receptor cDNA probe did not result in anyA
 .hybridizing product Fig. 1 .
3.5. Pharmacological characterization of transfected
CCK receptorsA
To identify the pharmacological profile of the
cloned CCK receptor cDNA sequence, the full-A
length cDNA insert from one clone was subcloned
into the vector pcDNAI at the Not I site, and tran-
siently expressed in COS-7 cells using DEAErde-
xtrane. The transfected COS-7 cells were incubated
for 60 min at 378C with the radiolabeled ligand
125I-BH-CCK alone, or in presence of increasing
concentrations of the unlabeled CCK receptor ago-
nists, CCK-8 and gastrin-17-I, and antagonists L-
364,718 and L-365,260. Inhibition of binding of radi-
olabeled CCK-8 by CCK-8 was half maximal half-
.maximal inhibition constants IC at 3.3"1.2050
 .nM. Gastrin-17-I IC s7.3"1.80 mM was 1000-50
fold less potent than CCK-8. The CCK receptorA
preferring antagonist L-364,718 IC s1.65"0.9550
.nM was 18-fold more potent than the CCK recep-B
tor preferring antagonist L-365,260 IC s29"3.4550
.nM . No binding activity was detected in untrans-
fected COS-7 cells and nonsaturable binding was
 .always less than 20% of saturable binding Fig. 2 .
3.6. Pharmacological characterization of transfected
CCK receptorsB
After transfection with the isolated CCK receptorB
cDNA COS-7 cells were incubated with the radiola-
beled ligand 125I-BH-CCK alone, or in presence of
increasing concentrations of CCK-8 and gastrin-17-I,
and L-364,718 and L-365,260, for 60 min at 378C.
For CCK-8 the half-maximal inhibition constant
 .IC was at 5.3"2.47 mM, and was nearly equipo-50
tent to gastrin-17-I at inhibiting binding of radiola-
Fig. 2. Ability of CCK receptor agonists and antagonists to inhibit binding of 125I-BH-CCK-8 to COS-7 cells transfected with guinea-pig
 .gallbladder CCK receptor cDNA. COS-7 cells were transfected with pcDNAI containing either the CCK left or the CCK receptorA A B
 . 125  . cDNA right . I-BH-CCK-8 50 pM was incubated either alone or with increasing concentrations of agonists CCK-8 and
.  . gastrin-17-1 or antagonists L-364,718 and L-365,260 . Data are presented as the percent of the control saturable binding total binding
.in the presence of radiolabeled hormone alone minus binding in the presence of 1 mM CCK-8 . The results given are means of values
from at least three experiments performed in duplicate. Vertical bars are standard deviations from the mean.
( )A. de Weerth et al.rBiochimica et Biophysica Acta 1327 1997 213–221218
Fig. 3. Southern Blot analysis of guinea-pig genomic DNA after
restriction enzyme digestion 10 mg genomic DNA; lane 1:
BamH1rBsPMII, lane 2: BamH1r XmaI; as a negative control a
DNAse digestion of the genomic DNA was performed: lane 3:
BamH1rBsPMIIqDNAse digestion, lane 4: BamH1r XmaIq
.DNAse digestion . This step was followed by hybridization with
CCK receptor cDNA A: low-stringency conditions, B: high-A
. stringency conditions and CCK receptor cDNA C: low-strin-B
.gency conditions, D: high-stringency conditions . The hybridiza-
tion pattern remains unchanged.
125  .belled I-BH-CCK IC s7.9"1.91 mM . L-50
 .365,260 IC s420"1.02 mM was equally potent50
as CCK-8, and 71-fold more potent compared to the
CCK receptor preferring antagonist L-364,718 ICA 50
.s5.9"1.35 mM .
No binding activity was detected in untransfected
COS-7 cells and nonsaturable binding was always
 .less than 20% of saturable binding Fig. 2 .
3.7. Southern blot analysis
Southern blot hybridization using 10 mg of restric-
tion enzyme digested genomic DNA from guinea-pig
hybridized with either the 32P random primed CCKA
or CCK receptor probe under both low- and high-B
stringency conditions resulted in a pattern of multiple
restriction enzyme products that remained unchanged
under both low- and high-stringency conditions Fig.
.3 .
4. Discussion
The present study provides strong evidence that
gastric smooth muscle cells from guinea-pig possess
both CCK and CCK receptors. It has long beenA B
established that CCK and gastrin, at physiological
and pharmacological doses, stimulate gastric motility
w x4,8,25 . It has been shown that CCK receptors medi-
ate this effect via receptors, which are localized
w xpredominately in the pyloric region 26,27 . Further
studies demonstrated that gastric smooth muscle cells
posses CCK receptors, occupation of which leads to
w xcell contraction 5–7 . However, there has been con-
siderable controversy which type of CCK receptor is
expressed in stomach smooth muscle cells.
So far most studies examining CCK and CCKA B
receptors on stomach smooth muscle cells have been
limited to studies of binding of radiolabeled ligands
and affinity labeling techniques. In this study we took
advantage of the availability of the two cloned CCK
 . w xreceptor cDNAs CCK and CCK receptors 21,23A B
to unequivocally address the question which CCK
receptor subtypes are expressed in this tissue.
Before the mRNA was prepared we separated
smooth muscle cells from other contaminating tissues
w x6 such as neural or epithelial cells, known to ex-
w xpress CCK receptors 15,28 . The results of the hy-
bridization screening of a cDNA library constructed
from this smooth muscle preparation of guinea-pig
stomach with 32P-labeled CCK and CCK receptorA B
probes, suggest expression of two distinct CCK re-
ceptors, which can be classified as CCK and CCKA B
receptors based on the high homologies towards the
w xalready cloned receptor cDNAs 15,16,19,20,22,23 .
In addition, when the receptor cDNAs isolated from a
cDNA library of a stomach smooth muscle prepara-
tion were transiently transfected into mammalian
cells, the pharmacological evaluation using agonists
and antagonists revealed the respective receptor types.
The expression of CCK receptors could be demon-B
strated by the finding that radiolabeled 125I CCK-8
binding was inhibited by CCK 8 and gastrin-17-I
with similar potencies CCK-8-IC 5.3 mM, gastrin-50
.17-IC 7.9 mM . Furthermore, L-365,260 was 17-50
fold more potent compared to the CCK receptorA
preferring antagonist L-364,718 L-364,718-IC 42050
.mM, L-365,260-IC 5.9 mM . These data confirmed50
w xthe findings on gastric 13 and gallbladder smooth
w xmuscle cells 19 which showed similar binding prop-
erties and indicate the existence of a typical smooth
muscle CCK receptor.B
Bitar et al. demonstrated that CCK-8 and gastrin
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are nearly equipotent in stimulating gastric smooth
muscle contraction, indicating the presence of only
w xone receptor type 9 , with the characteristics of the
above described CCK receptor subtype. Our find-B
ings are in agreement with these data, but describe
for the first time the additional expression of a sec-
ond CCK receptor subtype, the gastric smooth muscle
CCK receptor.A
The pharmacological profile of the cloned CCKA
stands in close agreement with studies performed on
isolated gallbladder smooth muscle cells and gall-
bladder tissue sections in guinea-pig known to ex-
w xpress CCK receptors 29,30 . The successful isola-A
tion of several clones representing the CCK recep-A
tor in this study supports findings by others, who
suspected that the guinea-pig stomach smooth muscle
w xcells posses two CCK receptor subtypes 31 . Specifi-
cally, Devazepide inhibited with similar potencies the
CCK-8 induced contraction of isolated single smooth
muscle cells and amylase release from pancreatic
w xacini subtypes 31 , a process that is mediated by the
w xCCK receptor subtype 3 . In addition, CI-988A
blocked the response to pentagastrin in the presence
of 3 nM devazepide, a concentration shown to block
w xthe CCK receptor 1 . This finding can now beA
supported by the molecular evidence of specific re-
ceptor cDNA encoding a functional CCK receptorA
cloned from stomach smooth muscle cells. The iso-
lated receptor cDNAs might encode receptors, which
are localized in the pyloric region, where CCK recep-
tors have been localized using autoradiographical
w xstudies 26,27 . We conclude that this receptor cloned
from guinea-pig stomach smooth muscle represents
the CCK receptor subtype expressed in intestinalA
smooth muscle cells.
The assumption that intestinal CCK receptors con-
sist of a population of only CCK and CCK sub-A B
types was further validated by the cDNA library
hybridization technique with different levels of strin-
gencies. Results of hybridization using both receptor
cDNAs under lower-stringency conditions did not
yield additional clones, confirming that neither of the
used receptor cDNAs has a functionally related coun-
terpart encoded by a different but highly homologous
cDNA sequence.
Although the methods used to isolate potential
additional subtypes were highly sensitive there are
theoretical possibilities that certain CCK receptor
 .subtypes were missed. First, we used a oligo dT
primed library, which was size selected. A smaller
gene than 1.8 kB would not be included in the cDNA
pool used to construct the library, and thus missed by
subsequent library screening. Recent reports describe
truncated isoforms of the CCK receptor generatedB
w xby the same gene 32 and potential splice variants
w x33 . Smaller isoforms and splice variants might not
be identified by screening a size selected cDNA
library. Secondly, a long 3X extension beyond the
carboxy terminal of the receptor might be responsible
for the observed absence of additional subtypes. This
problem could be avoided by using a randomly primed
cDNA library which was not done in this study. We
 .chose the oligo dT priming technique in order to
avoid the generation of cDNA fragments that lack the
full-length coding sequence of the cloned peptide.
Although hybridization screening and the polymerase
chain reaction are highly sensitive methods to isolate
rare transcripts, the level of expression in this tissue
might still be lower than the detection limit of the
method used. Fourth, the structure of a functional
CCK receptor additional to the isolated subtypes
might be so different, that the corresponding gene
does not hybridize with the used receptor cDNA
probes. The description of a 78-kDa gastrin-binding
w xprotein, which has been named CCK-C receptor 34
might fulfill these criteria, and would be missed by
employing the methods used in this study.
To rule out the existence of highly homologous
genomic sequences, which could encode for addi-
tional receptor subtypes we used restriction enzyme
digested genomic DNA and compared the hybridiz-
ing digested fragments under several stringency con-
ditions. No hybridizing fragments were identified
under low-stringency conditions that did remain un-
der high-stringency conditions. We conclude that
there are only two genes encoding for CCK receptors
present in the guinea-pig genome.
The molecular characterization and isolation of
only two subtypes of the CCK receptors in guinea-pig
stomach smooth muscle stands in contrast to a variety
of studies. Additional CCK receptors as describedB
by Grider et al., who provided evidence of a receptor
displaying the functional properties of a novel CCK
receptor, with a high affinity for gastrin, combined
with a pharmacological antagonist profile similar to
w xthe CCK receptor 6 , could not be found withB
( )A. de Weerth et al.rBiochimica et Biophysica Acta 1327 1997 213–221220
molecular tools employed in this study. Affinity la-
beling studies on several tissues have also been em-
ployed to identify proteins which might represent
potential CCK receptor subtypes. These studies
demonstrated considerable heterogeneity of CCK re-
ceptors in tissues derived from stomach. Whereas
125I-Bolton-Hunter-CCK 33 labeled a predominant
protein of M 80 000 on pancreatic plasma mem-r
w xbranes 35 , other decapeptide analogues identified a
w xM 85 000–95 000 glycoprotein in this tissue 36 .r
The molecular weight reported for bovine gallbladder
w xCCK receptor was M 70 000–85 000 37 . Severalr
studies described substantial differences in the molec-
ular weight of the CCK receptors in gastric smooth
muscle. Labeled protein subunits of M 55 000,r
w x75 000, 100 000 and 120 000 were reported 38 , sug-
gesting structural different CCK receptors in stomach
smooth muscle as identified in human leiomyosarco-
w x w xmas 36 compared to gallbladder smooth muscle 37
w xand pancreatic acini 39 . The calculated molecular
weight of the cloned CCK receptor in stomachA
smooth muscle as shown in this study is M 48 200.r
Technical difficulty in obtaining CCK receptor en-A
riched membranes from gallbladder smooth muscle in
small animals may be responsible for the observed
discrepancy. Furthermore, the contribution of N-lin-
ked carbohydrates to the apparent differences in size
was reported to be considerable. Shifting of the pro-
tein mobility after endoglycosidase treatment from
M 85 000–95 000 to M 42 000 supports this possi-r r
w xbility 39 . We cannot explain the difference in func-
tional and binding properties of these receptors in
vivo and in vitro, but it cannot be ruled out that
posttranslational processing in different tissues can
contribute to the observed differences.
The lack of a hybridizing fragment for CCKA
receptor mRNA in guinea-pig smooth muscle is not
surprising and might be due to the lack of sensitivity
w xof the Northern blot hybridization technique 24 .
Similar findings have been reported for the CCKA
receptor in rat brain, where only RT-PCR could
w xdemonstrate receptor expression in this tissue 22 .
The relative distribution of mRNA, which is repre-
sented by the absolute number of isolated clones 13
CCK receptor cDNA clones vs. 52 CCK receptorA B
.cDNA clones , might be an additional explanation.
The existence of CCK receptor cDNA in stom-A
ach smooth muscle as demonstrated in this study
stands in contrast to the absence of pharmacological
evidence of CCK receptors in several in vitro stud-A
ies. This obvious difference might be explained by
the existence of a very low affinity state of the CCKA
receptor explained by a newly defined multi-affinity-
state kinetic model, which stands in contrast to the
previously reported two-site stoichiometric model
w x40 .
In summary, our results demonstrate that the gas-
tric smooth muscle cell possesses two CCK receptor
subtypes, the CCK and CCK receptors. There isA B
no molecular evidence that previously reported tissue
specific additional subtypes exist in this tissue. The
cloning of the CCK and CCK receptors in guinea-A B
pig smooth muscle will provide a new important tool
to examine the physiological role of CCK andA
CCK receptors in the regulation of gastrointestinalB
motility in vivo and in vitro. This should have major
implications for future pharmacological strategies
aimed at selectively altering tissue function.
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